NOS3 and Hyperglycemia: In our study, we observed that treatment with NaHS in primary cardiomyocytes subjected to hyperglycemia, HR, or both conditions increased BH4 levels (Figure 6C) and decreased BH2 levels (Figure 6D), thus promoting eNOS coupling.